News Briefs

Life sciences VC firm AmorChem promotes McBride to GP

AmorChem is a Canadian early-stage venture capital firm focused on life sciences.

-
  • McBride first joined AmorChem in 2012
  • Based in Montreal, AmorChem was launched in 2011
  • The firm has financed over 30 university projects and started up several biotechnology companies from the fruits of this research

AmorChem, a Canadian early-stage venture capital firm focused on life sciences, has promoted Kevin McBride to general partner.

McBride first joined AmorChem in 2012.

“Kevin brings a comprehensive understanding of fundamental and translational research which is a key component in setting portfolio strategy and lends him a credibility crucial to the attraction of partners, both financial and pharmaceutical,” said Ines Holzbaur, managing partner of AmorChem, in a statement. “It’s a pleasure to recognise the value of his work through this new title and function.”

Based in Montreal, AmorChem was launched in 2011 and today oversees more than C$85 million under management. The firm has financed over 30 university projects and started up several biotechnology companies from the fruits of this research.